Biggest News Aggregation in the World
📰 Resented News

Page 19 - Resented News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Resented. Real-time updates on events, politics, business and more.

New US data confirms that TetraGraph supports clinical decisions and assures patient safety

Recently presented abstract validates that the EMG-based TetraGraph is comparable to the laboratory standard technology MMG during all depths of neuromuscular blockade, confirming TetraGraphs ability... | April 18, 2023
Medical College Of Wisconsin United States Uppsala Lan Pia Renaudin International Anesthesia Research Society Department Of Anesthesiology

New Data Showing that Transgene and NEC's Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023

New Phase I data confirm promising immunogenicity and efficacy profile of TG4050, an individualized neoantigen cancer vaccine developed by Transgene in collaboration with NEC Corporation In the head
United States France General United Kingdom Institut Curie Alexandra Martinez Lucie Larguier

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings

Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in... | April 18, 2023
United States Hotel Washington District Of Columbia Fairfax Hospital Andrew Nelsen James Gagermeier

Immuneering Announces Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program; Accelerates Study Timeline

Data presented at AACR Annual Meeting support IMM-1-104s potential to address a broad population of patients with RAS mutant tumorsIMM-1-104 well tolerated with no dose limiting toxicities or... | April 18, 2023
United States United Kingdom San Diego Gina Nugent Kiki Patel Laurence Watts

Transgene - Preclinical Results Showing TG6050, a Novel Oncolytic Virus, induces Tumor Regression by Activating Innate and Adaptive immune responses presented at AACR

Invir.IO® based oncolytic virus TG6050, is armed with IL-12 and an anti-CTLA4 antibody. A Phase I trial (Delivir) recently started enrolling patients with advanced non-small cell lung cancer (NSCLC)
United States Transgene Euronext Lucie Larguier Ben Brahim Corporate Communications American Association For Cancer Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science